PulseGLP
PulseGLP Wiki

Meta Weight Loss Ad Trends

Observed Meta ad-market patterns around GLP-1, online prescription weight loss, compound positioning, and creative themes.

Last updated: 2026-05-26. This page is generated from the PulseGLP second brain and should be treated as market-intelligence context, not medical or legal advice.

Current Signal Snapshot

  • 3,045 matching patient-evidence rows in the last 180 days.
  • 1,124 matching Meta ad observations in the last 180 days.
  • 50 matching FDA warning-letter findings in the enforcement corpus.
  • Newest matching patient evidence was observed 5/22/2026.
  • Newest matching ad observation was seen 5/22/2026.

Patient Evidence Patterns

  • Top drug/entity mix in sampled evidence: GLP-1 (12), Semaglutide (10), Wegovy (7), Tirzepatide (3), Zepbound (2), Mounjaro (1).
  • Highest-volume sampled sources: r/GLP1 (12), r/Semaglutide (10), r/WegovyWeightLoss (7), r/Tirzepatide (3), r/Zepbound (2), r/Mounjaro (1).
  • Classification mix in sampled evidence: Neutral-Low (14), Risk-Alert (10), Analytical (7), Positive (5).
  • Use Ask Pulse to inspect source-level citations before turning this signal into campaign copy, clinical workflow changes, or compliance guidance.

FDA And Compliance Context

  • Most common matching warning-letter finding types: product-sourcing-ambiguity (17), other-fda-cited-claim (1).
  • Recent companies/products represented in matching findings include Belle Health LLC dba Belle / Drugs; Dripgym Mobile Parent, LLC dba Amp Health / Drugs; Alan Health Technologies Inc. dba Alan / Drugs; 24HrDoc, Inc. dba 24HrDoc / Drugs; NewSelf Limited dba NewSelf / Drugs.
  • PulseGLP tracks potential FDA-cited language patterns; it does not determine whether a claim is compliant or non-compliant.

Ad Market Signals

  • Advertisers appearing in the sampled matching set: Sarah Mitchell (3), Zimmerman Reed (3), American Health Report (2), 40 Plus & Fabulous (1), BeSlimMD Weight Loss (1), Decalo Weight Loss (1).
  • Creative Intelligence can inspect the underlying ads for risk-level labels, themes, landing URLs, and repeated positioning patterns.
  • Ad counts reflect observed library rows and can include deduped or updated observations from recovered collection runs.

How Ask Pulse Uses This Page

  • Ask Pulse retrieves this page as durable context before it looks at fresh raw evidence.
  • The page helps keep answers consistent across repeated questions about the same topic.
  • Raw evidence citations are still required for specific factual claims or patient-language details.

Related PulseGLP Wiki Pages

4,219 matched sources Confidence 95/100 Updated 5/26/2026